HIV-1 Tat promotes age-related cognitive, anxiety-like, and antinociceptive impairments in female mice that are moderated by aging and endocrine status

[1]  F. Vidal,et al.  Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH) , 2021, Expert opinion on pharmacotherapy.

[2]  A. Rice,et al.  Conditional expression of HIV-1 Tat in the mouse alters the onset and progression of tonic, inflammatory, and neuropathic hypersensitivity in a sex-dependent manner. , 2020, European journal of pain.

[3]  R. Parker,et al.  Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy , 2020, The Journal of infectious diseases.

[4]  M. Schumacher,et al.  Pregnane steroidogenesis is altered by HIV-1 Tat and morphine: Physiological allopregnanolone is protective against neurotoxic and psychomotor effects , 2020, Neurobiology of Stress.

[5]  C. Mactutus,et al.  Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders , 2019, Journal of Neuroimmune Pharmacology.

[6]  M. Salahuddin,et al.  Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice , 2019, Hormones and Behavior.

[7]  Bryan R. Smith,et al.  Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy. , 2019, AIDS.

[8]  A. Ryan,et al.  Gait and Balance Biomechanics in Older Adults with and without HIV. , 2019, AIDS research and human retroviruses.

[9]  Rodney W. Johnson,et al.  Aging sensitizes male mice to cognitive dysfunction induced by central HIV-1 gp120 , 2019, Experimental Gerontology.

[10]  Canelif Yilmaz,et al.  Neurosteroids as regulators of neuroinflammation , 2019, Frontiers in Neuroendocrinology.

[11]  C. Mactutus,et al.  Neurorestoration of Sustained Attention in a Model of HIV-1 Associated Neurocognitive Disorders , 2019, Front. Behav. Neurosci..

[12]  J. Blanco,et al.  Gender differences for frailty in HIV-infected patients on stable antiretroviral therapy and with an undetectable viral load , 2019, PloS one.

[13]  J. Becker,et al.  HIV infection and age effects on striatal structure are additive , 2019, Journal of NeuroVirology.

[14]  M. Narasimhan,et al.  Sex Differences in a Rodent Model of HIV-1-Associated Neuropathic Pain , 2019, International journal of molecular sciences.

[15]  E. Masliah,et al.  Pathogenesis of age-related HIV neurodegeneration , 2019, Journal of NeuroVirology.

[16]  G. Birbeck,et al.  Global HIV neurology: a comprehensive review , 2019, AIDS.

[17]  J. Clements,et al.  HIV Eradication Strategies: Implications for the Central Nervous System , 2019, Current HIV/AIDS Reports.

[18]  E. Laan,et al.  Testosterone Insufficiency in Human Immunodeficiency Virus–Infected Women: A Cross-Sectional Study , 2018, Sexual medicine.

[19]  R. Greenblatt,et al.  Prolonged Amenorrhea and Resumption of Menses in Women with HIV. , 2018, Journal of women's health.

[20]  C. Depp,et al.  Psychosocial Correlates of Frailty Among HIV-Infected and HIV-Uninfected Adults , 2018, Behavioral medicine.

[21]  M. Gobbi,et al.  Plasma and Brain Concentrations of Doxycycline after Single and Repeated Doses in Wild-Type and APP23 Mice , 2018, The Journal of Pharmacology and Experimental Therapeutics.

[22]  T. Langford,et al.  Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-Sequencing , 2018, Scientific Reports.

[23]  C. Fennema-Notestine,et al.  White matter damage, neuroinflammation, and neuronal integrity in HAND , 2018, Journal of NeuroVirology.

[24]  K. Gee,et al.  Positive allosteric modulators of nonbenzodiazepine &ggr;-aminobutyric acidA receptor subtypes for the treatment of chronic pain , 2018, Pain.

[25]  Haomiao Jia,et al.  In people living with HIV (PLWH), menopause (natural or surgical) contributes to the greater symptom burden in women: results from an online US survey , 2018, Menopause.

[26]  Jinpu Yang,et al.  Andrographolide Inhibits Mechanical and Thermal Hyperalgesia in a Rat Model of HIV-Induced Neuropathic Pain , 2018, Front. Pharmacol..

[27]  A. Rice,et al.  Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy , 2018, Pain reports.

[28]  J. Hapgood,et al.  Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels , 2018, PloS one.

[29]  D. Langford,et al.  Cocaine and HIV‐1 Tat disrupt cholesterol homeostasis in astrocytes: Implications for HIV‐associated neurocognitive disorders in cocaine user patients , 2018, Glia.

[30]  P. Knapp,et al.  CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward , 2017, Brain, Behavior, and Immunity.

[31]  J. Kramer,et al.  Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years , 2017, Journal of acquired immune deficiency syndromes.

[32]  M. Kaufman,et al.  Conditional Human Immunodeficiency Virus Transactivator of Transcription Protein Expression Induces Depression-like Effects and Oxidative Stress. , 2017, Biological psychiatry. Cognitive neuroscience and neuroimaging.

[33]  H. Xiong,et al.  The P2X7 receptor in dorsal root ganglia is involved in HIV gp120-associated neuropathic pain , 2017, Brain Research Bulletin.

[34]  H. Fox,et al.  Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals , 2017, Journal of NeuroVirology.

[35]  Angela Aziz-Donnelly,et al.  Update of HIV-Associated Sensory Neuropathies , 2017, Current Treatment Options in Neurology.

[36]  N. Nakasujja,et al.  Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda , 2017, Neurology.

[37]  N. Sacktor.  Changing clinical phenotypes of HIV-associated neurocognitive disorders , 2017, Journal of NeuroVirology.

[38]  J. Fields,et al.  Human Immunodeficiency Virus Promotes Mitochondrial Toxicity , 2017, Neurotoxicity Research.

[39]  Lu Yang,et al.  Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND , 2017, Journal of Neuroimmune Pharmacology.

[40]  R. Paul,et al.  Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study , 2017, AIDS care.

[41]  M. Ortega,et al.  Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era , 2016, Journal of acquired immune deficiency syndromes.

[42]  D. Reddy,et al.  Clinical Potential of Neurosteroids for CNS Disorders. , 2016, Trends in pharmacological sciences.

[43]  P. Knapp,et al.  5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat , 2016, Brain, Behavior, and Immunity.

[44]  William D. Marks,et al.  HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulations , 2016, Journal of NeuroVirology.

[45]  Matthijs Vink,et al.  Prefrontal cortical thinning in HIV infection is associated with impaired striatal functioning , 2016, Journal of Neural Transmission.

[46]  H. Bimonte-Nelson,et al.  Modeling menopause: The utility of rodents in translational behavioral endocrinology research. , 2016, Maturitas.

[47]  David J. Volsky,et al.  HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment , 2016, Nature Reviews Neurology.

[48]  C. Sabin,et al.  The menopause transition in women living with HIV: current evidence and future avenues of research , 2016, Journal of virus eradication.

[49]  N. Sacktor,et al.  Cognitive Impairment Among Older Individuals with HIV Infection , 2016, Current Geriatrics Reports.

[50]  A. Sadosky,et al.  Burden of HIV-Related Neuropathic Pain in the United States , 2016, Journal of the International Association of Providers of AIDS Care.

[51]  I. Vetter,et al.  The thermal probe test: A novel behavioral assay to quantify thermal paw withdrawal thresholds in mice , 2016, Temperature.

[52]  P. Knapp,et al.  Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[53]  J. Margolick,et al.  Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men , 2016, Journal of acquired immune deficiency syndromes.

[54]  J. McLaughlin,et al.  Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice , 2015, Behavioural Brain Research.

[55]  M. Aksenova,et al.  HIV-1 Tat and cocaine mediated synaptopathy in cortical and midbrain neurons is prevented by the isoflavone Equol , 2015, Front. Microbiol..

[56]  L. Trautmann,et al.  The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency , 2015, mBio.

[57]  E. Cadenas,et al.  Perimenopause as a neurological transition state , 2015, Nature Reviews Endocrinology.

[58]  R. Cohen,et al.  HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? , 2015, Alzheimer's Research & Therapy.

[59]  Johanna L. Goderre,et al.  Impact of CD4+ Lymphocytes and HIV Infection on Anti‐Müllerian Hormone Levels in a Large Cohort of HIV‐infected and HIV‐uninfected Women , 2015, American journal of reproductive immunology.

[60]  G. Guaraldi,et al.  Hypogonadism in the HIV-infected man. , 2014, Endocrinology and metabolism clinics of North America.

[61]  M. Ferguson,et al.  Gp120 in the pathogenesis of human immunodeficiency virus–associated pain , 2014, Annals of neurology.

[62]  J. McLaughlin,et al.  Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS , 2014, Hormones and Behavior.

[63]  H. Kenna,et al.  Prospective Randomized Trial to Assess Effects of Continuing Hormone Therapy on Cerebral Function in Postmenopausal Women at Risk for Dementia , 2014, PloS one.

[64]  M. Schumacher,et al.  Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors , 2014, Progress in Neurobiology.

[65]  R. Ellis,et al.  HIV and Aging: Effects on the Central Nervous System , 2014, Seminars in Neurology.

[66]  D. Goldmeier,et al.  Hypogonadism in Human Immunodeficiency Virus-Positive Men , 2014, Korean journal of urology.

[67]  M. Aksenova,et al.  Synaptodendritic recovery following HIV Tat exposure: Neurorestoration by phytoestrogens , 2014, Journal of neurochemistry.

[68]  M. Miles,et al.  Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior , 2013, Brain Structure and Function.

[69]  C. del Rio,et al.  HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy , 2013, Obstetrics and gynecology international.

[70]  P. Calabresi,et al.  Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein , 2013, Proceedings of the National Academy of Sciences.

[71]  Sara E Looby,et al.  Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus–infected women , 2013, Menopause.

[72]  M. Kaufman,et al.  Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[73]  T. Krahe,et al.  Synaptic Dysfunction in the Hippocampus Accompanies Learning and Memory Deficits in Human Immunodeficiency Virus Type-1 Tat Transgenic Mice , 2013, Biological Psychiatry.

[74]  Mardge H. Cohen,et al.  Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the women's interagency HIV study (WIHS). , 2013, The Journal of clinical endocrinology and metabolism.

[75]  P. Knapp,et al.  Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice. , 2012, European journal of pharmacology.

[76]  R. Fromentin,et al.  An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription. , 2012, Cell host & microbe.

[77]  Florin Vaida,et al.  Independent Effects of HIV, Aging, and HAART on Brain Volumetric Measures , 2012, Journal of acquired immune deficiency syndromes.

[78]  M. Kaufman,et al.  Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse , 2012, Behavioural Brain Research.

[79]  S. Spector,et al.  Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein. , 2012, Infectious disorders drug targets.

[80]  G. Guaraldi,et al.  Premature Decline of Serum Total Testosterone in HIV-Infected Men in the HAART-Era , 2011, PloS one.

[81]  R. Dantzer,et al.  Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: A possible mechanism for AIDS comorbid depression , 2011, Brain, Behavior, and Immunity.

[82]  P. Micevych,et al.  The Neurosteroid Progesterone Underlies Estrogen Positive Feedback of the LH Surge , 2011, Front. Endocrin..

[83]  K. Shah,et al.  Direct Effects of HIV-1 Tat on Excitability and Survival of Primary Dorsal Root Ganglion Neurons: Possible Contribution to HIV-1-Associated Pain , 2011, PloS one.

[84]  W. Powderly,et al.  Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[85]  A. Weinberg,et al.  Effect of menstrual cycle variation in female sex hormones on cellular immunity and regulation. , 2011, Journal of reproductive immunology.

[86]  Jianhui Zhong,et al.  Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment , 2011, AIDS.

[87]  D. Neau,et al.  Menopause and HIV infection: age at onset and associated factors, ANRS CO3 Aquitaine cohort , 2011, International journal of STD & AIDS.

[88]  J. Ramaekers,et al.  Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype , 2011, Psychopharmacology.

[89]  A. Nath,et al.  Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. , 2010, The American journal of pathology.

[90]  P. Allebeck,et al.  Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda , 2010, BMC psychiatry.

[91]  Sterling C. Johnson,et al.  White Matter in Aging and Cognition: A Cross-Sectional Study of Microstructure in Adults Aged Eighteen to Eighty-Three , 2010, Developmental neuropsychology.

[92]  F. Vaida,et al.  Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. , 2010, Archives of neurology.

[93]  J. Parsons,et al.  Loneliness and HIV-related stigma explain depression among older HIV-positive adults , 2010, AIDS care.

[94]  Richard F. Thompson,et al.  Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease , 2010, Proceedings of the National Academy of Sciences.

[95]  A. Bruce-Keller,et al.  Estrogen receptor alpha inhibits the estrogen-mediated suppression of HIV transcription in astrocytes: implications for estrogen neuroprotection in HIV dementia. , 2009, AIDS research and human retroviruses.

[96]  Terry L. Jernigan,et al.  White matter tract injury and cognitive impairment in human immunodeficiency virusinfected individuals , 2009, Journal of NeuroVirology.

[97]  I. Grant,et al.  Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders , 2009, Neuropsychology Review.

[98]  N. Santoro,et al.  HIV and the menopause , 2008, Menopause international.

[99]  A. Nath,et al.  Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV‐1 tat transgenic mice , 2008, Glia.

[100]  J. Manson,et al.  Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society , 2008, Menopause.

[101]  P. Čičovački.  SOCIETY , 2008, Society.

[102]  Andrew S.C. Rice,et al.  Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy , 2007, PAIN®.

[103]  M. Schumacher,et al.  Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. , 2007, Endocrinology.

[104]  N. Morone,et al.  Mind-body interventions for chronic pain in older adults: a structured review. , 2007, Pain medicine.

[105]  A. Moore,et al.  The social consequences for older people of neuropathic pain: a qualitative study. , 2007, Pain medicine.

[106]  K. Kasischke,et al.  HIV-1 Trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons , 2007, The Journal of Immunology.

[107]  K. Kasischke,et al.  HIV-1 Trans Activator of Transcription Protein Elicits Mitochondrial Hyperpolarization and Respiratory Deficit, with Dysregulation of Complex IV and Nicotinamide Adenine Dinucleotide Homeostasis in Cortical Neurons1 , 2007, The Journal of Immunology.

[108]  D. M. Conde,et al.  Menopause symptoms in women infected with HIV: Prevalence and associated factors , 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[109]  M. Magnani,et al.  Candidate HIV-1 Tat vaccine development: from basic science to clinical trials. , 2006, AIDS.

[110]  R. Marcus,et al.  The role of calcium in peri- and postmenopausal women: 2006 position statement of The North American Menopause Society , 2006, Menopause.

[111]  A. Nath,et al.  Estradiol negatively regulates HIV-LTR promoter activity in glial cells. , 2006, AIDS research and human retroviruses.

[112]  J. Berman,et al.  HIV tat and neurotoxicity. , 2006, Microbes and infection.

[113]  S. Grinspoon.  Androgen deficiency and HIV infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[114]  Y. Lo,et al.  HIV infection, drug use, and onset of natural menopause. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[115]  Kiralee M. Hayashi,et al.  Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[116]  A. Nath,et al.  Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism , 2005, BMC Neuroscience.

[117]  S. File,et al.  Animal Tests of Anxiety , 2004, Current protocols in pharmacology.

[118]  Y. Liu,et al.  Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort , 2004, Journal of Neuroimmunology.

[119]  O. Selnes,et al.  Higher frequency of dementia in older HIV-1 individuals , 2004, Neurology.

[120]  J. Crabbe,et al.  Strain differences in three measures of ethanol intoxication in mice: the screen, dowel and grip strength tests , 2003, Genes, brain, and behavior.

[121]  A. Dobs.  Role of testosterone in maintaining lean body mass and bone density in HIV-infected patients , 2003, International Journal of Impotence Research.

[122]  A. Sönnerborg,et al.  Painful and non‐painful neuropathy in HIV‐infected patients: an analysis of somatosensory nerve function , 2003, European journal of pain.

[123]  T. Ten Have,et al.  Depressive and anxiety disorders in women with HIV infection. , 2002, The American journal of psychiatry.

[124]  J. Atkinson,et al.  Neuropsychiatric aspects of HIV infection among older adults. , 2001, Journal of clinical epidemiology.

[125]  S. Bhasin,et al.  Neuroendocrine abnormalities associated with HIV infection. , 2001, Endocrinology and metabolism clinics of North America.

[126]  M. Mattson,et al.  HIV‐1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity , 2001, Journal of neurochemistry.

[127]  C. Sherbourne,et al.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. , 2001, Archives of general psychiatry.

[128]  John E. Roberts,et al.  Meta-analysis of the relationship between HIV infection and risk for depressive disorders. , 2001, The American journal of psychiatry.

[129]  G. Kroemer,et al.  Mitochondrial Control of Cell Death Induced by HIV‐1‐Encoded Proteins , 2000, Annals of the New York Academy of Sciences.

[130]  S. Maier,et al.  Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120 , 2000, Brain Research.

[131]  C. L. M. V. SClllE,et al.  Neuropathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[132]  D. Schoenfeld,et al.  Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. , 1998, The Journal of clinical endocrinology and metabolism.

[133]  V. De Rosa,et al.  Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[134]  B. Ferrell,et al.  Pain in cognitively impaired nursing home patients. , 1995, Journal of pain and symptom management.

[135]  S. H. Kim,et al.  Sympathectomy alleviates mechanical allodynia in an experimental animal model for neuropathy in the rat , 1991, Neuroscience Letters.

[136]  O. Burešová,et al.  Radial maze in the water tank: An aversively motivated spatial working memory task , 1985, Physiology & Behavior.

[137]  R. Ellis,et al.  HIV in the cART era and the mitochondrial: immune interface in the CNS. , 2019, International review of neurobiology.

[138]  Shue Liu,et al.  Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats , 2018, Neuroreport.

[139]  Giles R. Scuderi,et al.  A Comprehensive Review , 2017 .

[140]  R. Greenblatt,et al.  Use of antimüllerian hormone to predict the menopausal transition in HIV‐infected women , 2017, American journal of obstetrics and gynecology.

[141]  M. Kaufman,et al.  Conditional Tat protein brain expression in the GT-tg bigenic mouse induces cerebral fractional anisotropy abnormalities. , 2015, Current HIV research.

[142]  Suzie Thenin-Houssier,et al.  Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice. , 2015, Current HIV research.

[143]  Sujit Kumar Tripathy,et al.  Endocrine alterations in HIV-infected patients , 2015, Indian journal of endocrinology and metabolism.

[144]  J. Rabkin,et al.  Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. , 2006, The American journal of psychiatry.

[145]  L. Hudson,et al.  Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. , 2000, Journal of neurovirology.

[146]  S. Cohn,et al.  Perimenopausal symptomatology among HIV-infected women at least 40 years of age. , 2000, Journal of acquired immune deficiency syndromes.

[147]  M. Tagliati,et al.  Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. , 1999, Archives of neurology.

[148]  Calvin Hall,et al.  A study of the rat's behavior in a field : a contribution to method in comparative psychology , 1932 .

[149]  M. Loutfy,et al.  International Journal of Women's Health Dovepress Perspectives on Menopause and Women with Hiv , 2022 .